[ORGANIZATION]
Axsome Therapeutics
Featured in 2 tracked stories · first seen
Situations
Stingray Group fiscal 2027 financial reporting
2 clusters · 8 sources · last updated
Latest: Moneris to be sold by BMO and RBC to Francisco Partners for C$2 billion
Stingray Group Inc. announced its intention to release first-quarter fiscal 2027 financial results, covering the period ending June 30, 2026, on August 10, 2026. The company scheduled a conference call to discuss the per
Akebia Therapeutics Q2 financial and clinical results
2 clusters · 4 sources · last updated
Latest: Axsome Therapeutics reports 46% revenue growth in Q2 2026
Akebia Therapeutics reported second-quarter results characterized by a significant divergence in product performance. Revenue for its anemia drug, Vafseo, grew 60% year-over-year to $21.3 million, supported by a 41% sequ